Jump to main content
Jump to site search

Issue 2, 2016
Previous Article Next Article

High-density lipoproteins for therapeutic delivery systems

Author affiliations

Abstract

High-density lipoproteins (HDL) are a class of natural nanostructures found in the blood and are composed of lipids, proteins, and nucleic acids (e.g. microRNA). Their size, which appears to be well-suited for both tissue penetration/retention as well as payload delivery, long circulation half-life, avoidance of endosomal sequestration, and potential low toxicity are all excellent properties to model in a drug delivery vehicle. In this review, we consider high-density lipoproteins for therapeutic delivery systems. First we discuss the structure and function of natural HDL, describing in detail its biogenesis and transformation from immature, discoidal forms, to more mature, spherical forms. Next we consider features of HDL making them suitable vehicles for drug delivery. We then describe the use of natural HDL, discoidal HDL analogs, and spherical HDL analogs to deliver various classes of drugs, including small molecules, lipids, and oligonucleotides. We briefly consider the notion that the drug delivery vehicles themselves are therapeutic, constituting entities that exhibit “theralivery.” Finally, we discuss challenges and future directions in the field.

Graphical abstract: High-density lipoproteins for therapeutic delivery systems

Back to tab navigation

Publication details

The article was received on 04 Jul 2015, accepted on 19 Nov 2015 and first published on 24 Nov 2015


Article type: Highlight
DOI: 10.1039/C5TB01332A
Author version
available:
Download author version (PDF)
J. Mater. Chem. B, 2016,4, 188-197

  •   Request permissions

    High-density lipoproteins for therapeutic delivery systems

    R. Kannan Mutharasan, L. Foit and C. Shad Thaxton, J. Mater. Chem. B, 2016, 4, 188
    DOI: 10.1039/C5TB01332A

Search articles by author

Spotlight

Advertisements